|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.765 USD | +2.40% |
|
+0.36% | -29.27% |
| 09:09am | DiaMedica Therapeutics Receives US FDA Guidance on DM199 Nonclinical Requirements | MT |
| 05-20 | DiaMedica Therapeutics Says Trial of DM199 to Treat Acute Ischemic Stroke Reaches 75% Enrollment | MT |
Chart: Technical Analysis
- Stock Market
- Stocks
- DMAC Stock
- Charts DiaMedica Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
















